Chemist Body up against Swiggy-PharmEasy's 10-Minute Medicine Delivery Model, Seeks DCGI Intervention Farhat Nasim5 Nov 2024 4:04 PM ISTNew Delhi: The All India Organization of Chemists and Druggists (AIOCD) has voiced strong objections to a potential partnership between Swiggy...
Venus Remedies expands reach in ASEAN region with Malaysian PIC/S GMP nod for Pre-filled Syringe facility Ruchika Sharma5 Nov 2024 3:30 PM ISTMumbai: Venus Remedies Limited, a exporter of generic drugs with presence in more than 80 countries, has received Good Manufacturing...
Dr Reddy's Labs recalls over 3 lakh bottles of Cinacalcet tablets in US over manufacturing issues Ruchika Sharma5 Nov 2024 1:30 PM ISTNew Delhi: Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets, a medication used for treatment of high calcium...
Torrent Pharma promoter offloads 2.9 percent stake for Rs 3086 crore Ruchika Sharma5 Nov 2024 12:30 PM ISTNew Delhi: Torrent Investments, a promoter entity of Torrent Pharmaceuticals, has offloaded a total of 99.44 lakh shares or 2.94 per cent stake...
Natco Pharma names Imtiyaz Basade as Senior Vice President - RAD, Pharma Division, Kothur Unit Ruchika Sharma5 Nov 2024 11:24 AM ISTTelangana: Natco Pharma has announced that Imtiyaz Basade has been appointed as Senior Vice President - RAD, Pharma Division, Kothur Unit w.e.f....
Sun Pharma alopecia drug Leqselvi launch blocked in US Farhat Nasim4 Nov 2024 7:05 PM ISTNew Delhi: Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in...
CDSCO Panel Approves Pfizer Protocol Amendment proposal to study anti-cancer drug Elranatamab Dr. Divya Colin4 Nov 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Shilpa Medicare gets four USFDA observations for Bengaluru facility Ruchika Sharma4 Nov 2024 3:58 PM ISTRaichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four observations at the...
Biocon Biologics Bengaluru drug substance facility classified as VAI Ruchika Sharma4 Nov 2024 12:30 PM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' Drug Substance Facility at Biocon...
USFDA classifies Cipla Goa facility as VAI Ruchika Sharma4 Nov 2024 11:30 AM ISTMumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...
Sanofi Healthcare Gets CDSCO Panel Nod to Study Asthma Drug SAR443765 Dr. Divya Colin3 Nov 2024 5:15 PM ISTNew Delhi: The drug major Sanofi Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Intas Pharmaceutical Gets CDSCO Panels Nod to Conduct Phase III clinical trial of Ruxolitinib cream Dr. Divya Colin3 Nov 2024 5:00 PM ISTNew Delhi: Intas Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
